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Case Reports
Superior Vena Cava Thrombectomy with the X-SIZER1
Catheter System in a Child with Fontan Palliation
Jeffrey G. Gossett, MD, Albert P. Rocchini, MD, and Aimee K. Armstrong,* MD
A 4-year-old female with hypoplastic left heart syndrome and Fontan palliation presented
with severe neurologic impairment from thrombosis of the superior vena cava (SVC). She
underwent successful SVC thrombectomy with the X-SIZER1 Thrombectomy Catheter
System, followed by balloon angioplasty. She demonstrated rapid improvement in her
neurologic deficits after the procedure. This represents the first published use of the X-
SIZER in a child and its first published use for SVC thrombectomy. ' 2006 Wiley-Liss, Inc.
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INTRODUCTION
The final stage in surgical palliation for children with uni-
ventricular hearts is the Fontan procedure. During this surgery,
the systemic venous return is connected directly to the pulmo-
nary circulation. Since the flow within this circuit is passive,
even a small degree of obstruction can have significant clinical
impact on pulmonary blood flow and cardiac output [1].
Venous thromboses and superior vena cava (SVC) obstruction
in Fontan patients have been reported with significant morbid-
ity and mortality [2–5]. In addition, obstruction to SVC flow
can cause elevation in the venous pressure of the head, upper
extremities, and thorax, leading to SVC syndrome. With
severe obstruction, venous infarction can occur [6].
The X-SIZER1 Thrombectomy Catheter System (ev3,
Inc., Plymouth, MN) consists of a rotating helical cutter
attached to a vacuum reservoir. The catheter is advanced
through a thrombus over a wire, and clot and debris are
deposited into the vacuum container. The device has
been used in adults for thrombectomy in saphenous vein
grafts and native coronary arteries [7–9]. To date, there
has been no report of the use of the X-SIZER in a pedi-
atric patient or in the SVC. We present a case of SVC
thrombectomy with the X-SIZER, followed by balloon




The patient is a 4-year-old girl who was prenatally
diagnosed with hypoplastic left heart syndrome (HLHS)
and electively delivered at our institution. Because of
necrotizing enterocolitis, the Norwood procedure was
delayed until 17 days of age. She required reoperation
on the same day for residual ascending aortic obstruction
and could not be weaned from cardiopulmonary bypass.
She was transitioned to extracorporeal membrane oxy-
genation (ECMO) via thoracic cannulae. After four days,
she weaned from ECMO and was discharged 6 weeks
later.
She returned at 7 months of age for Hemi-Fontan sur-
gery, after which she required right hemi-diaphragm pli-
cation for diaphragmatic paralysis and thoracic duct liga-
tion for persistent chylous effusions. Prior to discharge,
echocardiogram revealed a possible thrombus in the
Hemi-Fontan baffle. Therefore, she underwent cardiac
catheterization, which did not show an obvious thrombus
in the baffle but did show the left innominate, left inter-
nal jugular (IJ), and left subclavian veins to be partially
occluded with thrombus. She was discharged 6 weeks
postoperatively on aspirin therapy. At 30 months of age,
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a lateral tunnel Fontan was performed with creation of a
4 mm fenestration. Preoperatively, her SVC was shown
to be widely patent by echocardiogram. Her postopera-
tive course was unremarkable, and low velocity, unob-
structed flow was documented by echocardiogram in her
SVC prior to discharge.
The patient was diagnosed with protein losing enter-
opathy 6 months after the Fontan operation. Then, at
4 years of age, she developed the acute onset of neuro-
logic changes, consisting of involuntary movements of
her right arm and leg and speech deficits. Evaluation at a
referring institution included multiple head CTs, which
were all normal, despite clinical concern for a cerebral
vascular accident. A tunneled central venous catheter
was placed in the right IJ vein, which led to swelling of
the right arm and head. After 3 weeks, the catheter was
removed with prompt resolution of the swelling, but the
neurologic symptoms worsened with loss of head control
and the ability to sit. She also developed choreoathetoid
movements and progressive dysarthria and oral apraxia.
At that time, echocardiogram and CT revealed possible
thrombus in her Fontan pathway and pulmonary arteries.
Therefore, she was referred to our institution for further
evaluation.
Our evaluation included a chest CT, which demon-
strated complete occlusion of the SVC with thrombus
(Fig. 1). The left IJ and innominate veins were also
occluded. An MRI of the brain was obtained and was
normal without evidence of edema, hemorrhage, or is-
chemic insult. As there was no evidence to support either
ischemic or hemorrhagic stroke, other etiologies of her
neurologic symptoms were ruled out, including toxic-
ities, vitamin deficiencies, infection, neoplasm, and rheu-
matologic disorders. With no identifiable etiology, it was
hypothesized that impairment of brain function, particu-
larly in the basal ganglia, could be caused by elevated
cerebral venous pressure from SVC thrombosis. The
patient was referred to the cardiac catheterization labora-
tory for attempted thrombectomy of her SVC.
Procedure
Continuous arterial pressure monitoring was per-
formed through an existing arterial line. A 7 French
sheath was placed in her right IJ vein, using ultrasound
guidance. The mean pressure in her right IJ vein was
25 mm Hg. A hand injection of contrast was performed
through the sheath, documenting occlusion of her SVC
and a small, tortuous collateral vessel supplying minimal
decompression (Fig. 2A). A 4 French Bentson–Hana-
fee–Wilson 1 glide catheter (Terumo Medical, Somerset
Fig. 1. Chest CT before intervention documenting occlusion of
the SVC by thrombus. SVC, superior vena cava; RA, right atrium;
LPA, left pulmonary artery; AAo, ascending aorta. Incidental
note is made of the large right pleural effusion.
Fig. 2. Angiography immediately before thrombectomy. (A) Complete occlusion of the SVC is
seen. A tortuous collateral vessel partially decompresses the cerebral venous circulation. (B)
The X-SIZER in the right IJ vein with a 0.014@wire through the area of thrombosis.
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NJ) and a 0.035@ 180 cm stiff angled glide wire (Terumo
Medical, Somerset NJ) were advanced easily through the
occluded SVC into the inferior vena cava (IVC). The
mean pressure in the Fontan pathway and IVC was 15
mm Hg. The glide wire was exchanged for a 0.014@
Steerable Stabilizer XS wire with a 3 cm tip (Cordis
Corp., Miami Lakes, FL), and the catheter was
exchanged for a 2 mm X-SIZER (Fig 2B). Multiple
passes through the SVC thrombus were made with the
X-SIZER until the 100 cc vacuum bottle was filled.
Because of the blood loss, 100 cc of packed red blood
cells (PRBC) were transfused into the patient. A repeat
angiogram was performed and demonstrated flow into
the Fontan pathway from the SVC but with residual
thrombus. Additional passes were made with the X-
SIZER until another 60 ml of debris and blood were
removed. A third angiogram showed continued increase
in the caliber of the SVC with flow into the left pulmo-
nary artery. Serial balloon dilations of the SVC were
then performed, first with a Tyshak II 8 mm 3 2 cm bal-
loon (B. Braun Medical Inc., Bethlehem, PA), then with
a 10 mm 3 3 cm balloon.
Repeat angiogram of the right IJ vein demonstrated
residual thrombus at the right IJ/SVC junction. Multiple
passes were made with the X-SIZER with removal of an
additional 30 ml of clot and blood from the right IJ, fol-
lowed by static dilation with the 8 mm angioplasty bal-
loon. An additional 100 cc of PRBC were transfused to
the patient. At that point, the mean pressure in the right
IJ was 20 mm Hg with a Fontan pathway pressure of
16 mm Hg. A final angiogram was performed showing a
patent SVC with brisk flow into the Fontan pathway and
pulmonary arteries with a few areas of small filling
defects (Fig. 3A and B). The patient tolerated the proce-
dure well with no complications. The total procedure
time was 127 min with 26 min of fluoroscopy time and
Fig. 3. Angiography of the SVC after thrombectomy in the AP (A) and lateral (B) projections
showing patency of the SVC with brisk flow into the Fontan pathway. There are small residual
filling defects at the SVC/Fontan junction.
Fig. 4. Angiography obtained 3 months after thrombectomy in the AP (A) and lateral (B) projec-
tions showing the widely patent SVC and Fontan pathway with the resolution of the filling
defects.
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28 cc of contrast delivered. The IJ venous sheath was
removed, and the patient was transported back to the in-
tensive care unit, where a heparin infusion was restarted.
Follow-up
During the following few days, her speech began to
improve, and the involuntary movements decreased. She
was transitioned from heparin infusion to warfarin, and
aggressive rehabilitation was undertaken. After a 6 week
hospitalization, she was discharged home ambulating
and speaking in short sentences with no involuntary
movements.
The patient returned to the cardiac catheterization lab-
oratory 3 months later for removal of a trans-hepatic pe-
ripherally inserted central catheter. Her SVC mean pres-
sure was 16 mm Hg with a Fontan pathway pressure of
15 mm Hg. SVC angiography showed a widely patent
SVC with no filling defects (Fig. 4A and B).
At the most recent follow-up, she was able to run and
to follow multi-step commands. Her speech was fluent,
but she exhibited some persistent, mild speech delay.
DISCUSSION
Embolic cerebrovascular accidents in patients with
single ventricles have been well described [3,10,11]. In
addition, obstruction of the SVC in patients with Fontan
circulation can lead to pulmonary embolism, which can
be catastrophic [3]. Neurologic changes due to SVC
obstruction, however, have not been reported in patients
with Fontan circulation. In our patient’s case, once cere-
brovascular accident had been ruled out, we hypothe-
sized that the elevation of cerebral venous pressure from
SVC thrombosis was causing her neurologic symptoms
that mimicked a stroke.
Given the severity of her neurologic deficits, we felt
that rapid relief of the obstruction was indicated. There
are limited data available on the optimal approach to
thrombectomy in the single ventricle patient. Surgical
and thrombolytic approaches have been attempted with
mixed results [1–5,12]. While these therapies were con-
sidered, the overall risks were felt to be higher than for
percutaneous intervention. We did not believe that bal-
loon angioplasty alone would adequately relieve the
obstruction, without preceding it by thrombectomy. We
also felt that SVC stenting might lead to later develop-
ment of thrombus within the stent [13]. Therefore, we
elected to attempt percutaneous thrombectomy, followed
by balloon angioplasty, in order to lower the cerebral ve-
nous pressure.
The AngioJet1 system (Possis Medical, Minneapolis,
MN) and the X-SIZER Thrombectomy Catheter System
were considered for the trans-catheter approach. There
have been two reports of the use of the AngioJet in
patients with Fontan circulation, including one adult
patient in whom it successfully removed a large pulmo-
nary embolism [14] and one child in whom it removed a
thrombus within a pulmonary artery stent [13]. The
major disadvantage of this system, however, is the siza-
ble financial outlay necessary. In a pediatric catheteriza-
tion laboratory, where the use of the device is limited,
the cost may be prohibitive. As the X-SIZER is a self-
contained, disposable system, no capital outlay is neces-
sary.
Using the same technique as has been described for
smaller vessels, the X-SIZER thrombectomy, followed
by balloon angioplasty, successfully relieved the SVC
obstruction with only minimal residual thrombus. The
patient’s rapid neurologic improvement, after decrease
in right IJ mean pressure, validates our diagnosis and
suggests that elevation in cerebral venous pressure was
the etiology for her neurologic changes. Repeat angiog-
raphy 3 months later documented excellent durability of
the results with no residual thrombus or stenosis.
A potential limitation of thrombectomy catheters is
that a wire must be passed through the lesion. In our
case, we were able to easily advance a glide wire
through the thrombus. Care must be taken to assure that
the wire does not perforate the vessel wall, as severe
hemorrhage could occur if the device were to be
advanced through the vessel wall. Another potential
limitation of the X-SIZER is the blood loss associated
with the vacuum technology. While this serves to
remove clot and debris, whole blood is also removed. In
our 16 kg patient, we removed a total of 200 cc of clot
and debris mixed with whole blood, which represents
13% of our patient’s total blood volume. We opted to
replace the loss with 200 cc of PRBC.
CONCLUSIONS
We report the successful use of the X-SIZER Throm-
bectomy Catheter System for SVC thrombectomy in a
child with Fontan palliation for HLHS. Severe neuro-
logic impairment, due to elevated cerebral venous pres-
sure from SVC thrombosis, was reversed after the
thrombectomy. To our knowledge, this is the first report
of neurologic complications from this etiology in a pedi-
atric patient with Fontan circulation. This is also the first
report of the use of the X-SIZER in a child and its first
use for SVC thrombectomy. Further investigation and
long-term follow-up is warranted to assess the use of this
device in the SVC and in children with congenital heart
disease.
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